Our People

Iqbal has been involved in the following notable private equity transactions (for strategic transactions, please see below):

• Represented Advent in:
  • its acquisition of controlling stake in Suven Pharma (a listed entity) for a total consideration of approx. USD 1+ billion – one of the largest control acquisitions of a listed pharma company in India by a PE sponsor
  • the USD 4+ billion reverse merger and listing of the Cohance platform with Suven Pharma – first of its kind and one of the largest transactions in India
• Represented Apax in its:
  • PIPE transaction in iGate and the follow-on acquisition of Patni – the largest LBO transaction (approx. USD 2.6 billion) in India then
  • global acquisition of EVRY ASA
  • simultaneous acquisition of Activant Group, Inc. (a private company) and Epicor Software Corporation (a public company) using the BK Structure for a total consideration of approx. USD 2 billion
• Represented Bain in its acquisition of Porus Labs for Rs. 2400 crs
• Represented Brookfield:
  • and Sagen (a Brookfield portfolio company) in their investment in IMGC – India’s First Mortgage Guarantee Insurance Company in India
• Represented Blue Water Energy in its:
  • acquisition of Sledgehammer Tools
  • acquisition of Severn Glocon Group
• Represented TPG:
  • the Rise Climate Fund and Evercare in their successful approx. USD 1 Billion exit from the Care Hospital Group and defence against first of its kind bear hug / hostile bid from Max Hospital – first of its kind hostile bid in India
  • and the Rise Climate Fund in their USD 1 Billion investment in Tata Motors EV subsidiary – one of the largest PE-EV transactions in the world and winner of multiple global deal of the year awards, including the IBJL 2022 Deal of the Year Award
  • and the Rise Fund in their follow-on investment in Fourth Partner Energy along with NorFund – one of the largest C&I solar market deals in the country
  • in its multi-jurisdictional investment and follow-on investments in Stelis Biopharma – to create one of the largest vaccine manufacturing platforms in the world
  • in its then proposed USD 1 Billion investment in Serum India Life Sciences to create one of the world’s largest vaccine platforms (withdrawn)
  • in its investment, and multiple follow-on investments, in Pharmeasy
  • in its investment in RIL – Retail Ventures
  • in its investment in RIL – Jio Platforms – winner of the IBLJ 2020 Star Deal Award
  • Evercare and CDC in their acquisition of majority stake in STS Hospitals – the largest deal in its sector in Bangladesh
  • and the Rise Fund in their acquisition of Abraaj’s global healthcare portfolio – one of the largest healthcare fund GP transactions globally then
  • and the Rise Fund in their buy-out of Care Hospital
  • and the Rise Fund in their acquisition of majority stake in Fourth Partner Energy
  • in its partial exit from Solara Active Pharma, a public listed company
  • in its investment in Solara Active Pharma, a public listed company
  • in its sale of Healthium to Apax – India’s first successful dual track exit and the largest medical devices transaction then
  • in its acquisition of Mothercare Hospitals
  • in its follow-on investment in Sutures, a medical devices manufacturer
  • in its portfolio company’s, i.e., Sutures’, cross-border bolt-on acquisition of Clinisupplies
  • and QRG in their investment in Campus Shoes
• Represented KKR in its “confidence capital” investment, i.e., in its NBFC in India
• Represented ADIA and Cinven, on the Indian leg, of their acquisition of LGC from KKR
• Represented Varde in its acquisition of shares of PNB Housing Finance from PNB
• Represented Goldman Sachs in its proposed investment in Manipal for its bid for Fortis (USD 1.2 Billion)
• Represented General Atlantic in its investment in D-Mart
• Represented The Partners Group:
  • and Kedaara Capital (the Indian strategic partner of Clayton, Dubilier & Rice) in their joint acquisition of Au Housing Finance
  • and certain other investors in their acquisition of Casadoce
• Represented NIIF:
  • in Govt. of India’s investment in NIIF
  • in its bid for Jet Airways
• Represented Temasek in its investment in Intas Pharma
• Represented Bessemer Venture Partners in its partial exist from Snapdeal (this deal won an IFLR award)
• Represented 40 North in its divestment of indirect shareholding in Clariant, an Indian public listed company
• Represented Apollo, its founders and its portfolio company, Hexion, in exiting its multi-billion-dollar acquisition of Huntsman – this transaction established the current U.S. key MAC related law
• Represented Abry in its acquisition of XAND
• Represented Greenbriar in its acquisition of Ryan Herco Flow Solutions
• Represented a global PE fund in its potential investment in KIMS Hospital chain
• Represented a global PE fund in its potential investment in Aster DM Hospital chain
• Represented a global PE fund in its then proposed investment in QuEST Global Services
• Represented certain PE buyers in their acquisition of the largest microfinance portfolio from a group of developmental organisations, including the IFC (one of the largest transactions in this sector)

Iqbal has been involved in the following notable strategic transactions:

• Represented Tata Group:
  • in its automotive joint venture with the BMW Group
  • and the Jaguar Land Rover in their setup of a manufacturing facility with the Govt. of Tamil Nadu
  • in its potential multiple billion-dollar fund raise of the EV business
• Represented Poonawalla Group in its acquisition of 50% stake in Dharma Productions
• Represented Reliance:
  • and Viacom in their USD 8.5+ billion merger with Disney India – the largest TMT transaction in India
  • joint venture with Brookfield and DLR to create one of the largest data center JVs in the world
  • acquisition of a major movie studio in India
  • multiple joint ventures with various international brands, including Juicy Couture, Brooks Brothers and Muji
  • joint venture with STAR TV for the Indian Soccer League
• Represented Ultratech in its then proposed USD 10+ Billion acquisition bid for Holcim’s Indian cement assets (Ambuja and ACC)
• Represented Biocon Biologics in its:
  • acquisition of Viatris’ Biosimilars Assets for approx. USD 4.1 Billion in stock and cash – the largest transaction of its kind by an Indian acquirer and a winner of multiple awards
  • strategic agreement with Serum India Life Science (SILS), and SILS’ investment in Biocon Biologics – this is one of the largest vaccine strategic alliance deals in the world
• Represented PharmEasy in its:
  • acquisition of Thyrocare – the largest, and first of its kind, acquisition of an Indian public listed company by an Indian unicorn
  • fund raise from the Thyrocare investor – first of its kind cyclical transaction with a public listed entity in India
• Represented L&T in its divestiture of the Electrical and Automation business through a competitive auction process to Schneider (transaction value approx. USD 2.2 Billion) – one of the largest direct FDI transactions in India (winner of multiple awards globally)
• Represented Byjus in its negotiations with David Kemper and investment by Ranjan Pai
• Representing Amazon in its implementation of the global Kuiper Satellite network
• Represented OMERS in its investment in HDFC (overall transaction value approx. USD 1.1 Billion)
• Represented SREI group in its restructuring of its lease, rental and equipment finance businesses
• Represented Asian Paints in its acquisition of Causeway paints, a Sri Lankan company
• Represented Vodafone for one of the largest tech outsourcing agreements in the world with IBM
• Represented Surya Hospitals in providing an exit to the existing investor and further investment by Sea Link
• Represented Sumitomo in its joint venture with the Mahindra group relating to the agro chemical business
• Represented a large Indian bank in its bid for RBS (withdrawn)
• Represented a Chinese buyer in its bid for Acceyla Group, a public listed company
• Represented K-Hospitality, a leading Indian hospitality company, in its:
  • restructuring and domestic and overseas expansion through joint ventures, franchising and acquisitions
  • acquisition of certain business assets from Everstone
• Represented Mahyco in its acquisition of a controlling stake in Quton, the largest seed company in Africa currently present in Zimbabwe, Malawi and Tanzania
• Represented Wolters Kluwer in its buy-out of DataCert Consulting
• Represented the Special Committee of the Board of Directors of a major global manufacturer of hydraulic and electronic systems and component maker in connection with the acquisition by the parent company for USD 2.8 billion
• Represented Dainippon Sumitomo Pharma in its acquisition of Sepracor for USD 2.6 billion
• Represented Sumitomo Metal Industries in its multi-billion-dollar joint venture with Vallourec and Mannesmann Tubes
• Represented William Morris Agency in its multi-billion-dollar merger with The Endeavor Agency
• Represented Avenue in its Chapter 11 reorganization and Section 363 auction process